Global Transcatheter Mitral Valve Replacement Market 2016-2020

  • ID: 3795207
  • Report
  • Region: Global
  • 46 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Edwards Lifesciences
  • MitrAssist
  • Neovasc
  • Valtech
  • MORE
About Mitral Valve

The mitral valve manages blood flow from the left atrium to the left ventricle. The valve prevents the backward flow of the blood. Mitral regurgitation is a common mitral valve disorder that causes the abnormal backward flow of the blood. Cardiologists use mitral surgical valve repair procedures or transcatheter replacement procedures to treat this disorder. About 80,000 individuals undergo these two procedures for treating the disorder.

The analysts forecast the global transcatheter mitral valve replacement market to grow at a CAGR of 21.93% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global transcatheter mitral valve replacement market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of transcatheter mitral valve implants.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Transcatheter Mitral Valve Replacement Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Edwards Lifesciences
- Micro Interventional Devices
- Neovasc

Other prominent vendors
- MitrAssist
- NaviGate Cardiac Structures
- Valtech
- Boston Scientific
- Medtronic

Market drivers
- Use of minimally invasive procedures

Market challenges
- Stringent regulatory framework

Market trends
- Increase in M&A

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Edwards Lifesciences
  • MitrAssist
  • Neovasc
  • Valtech
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Transfemoral implantation
  • Transapical implantation
PART 07: Reimbursement and economics of transcatheter mitral valve replacement in US
  • Reimbursement for transcatheter mitral valve replacement
  • Economic impact of transcatheter mitral valve replacement
PART 08: Geographical segmentation
  • Transcatheter mitral valve replacement market in Americas
  • Transcatheter mitral valve replacement market in EMEA
  • Transcatheter mitral valve replacement market in APAC
PART 09: Market drivers
  • Prevalence of mitral regurgitation
  • Use of minimally invasive procedures
  • Use of transcatheter mitral valve replacement in high-risk individuals
PART 10: Impact of drivers

PART 11: Market challenges
  • Availability of alternative treatment
  • Stringent regulatory framework
  • Lack of skilled personnel
PART 12: Impact of drivers and challenges

PART 13: Market trends
  • Development of novel products
  • Increase in M&A
  • Focus on US
PART 14: Vendor landscape
  • Competitive scenario
  • Product portfolio matrix
PART 15: Key vendor analysis
  • Abbott Laboratories
  • Edwards Lifesciences
  • Micro Interventional Devices
  • Neovasc
  • Other prominent vendors
PART 16: Appendix
  • List of abbreviations
PART 17: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Global transcatheter mitral valve replacement market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global transcatheter mitral valve replacement market segmentation by product
Exhibit 05: Comparison of transfemoral and transapical implantation
Exhibit 06: Global transcatheter mitral valve replacement market segmentation by geography 2015
Exhibit 07: Global transcatheter mitral valve replacement market segmentation by geography 2020
Exhibit 08: Global transcatheter mitral valve replacement market segmentation by geography 2015-2020
Exhibit 09: Transcatheter mitral valve replacement market in Americas 2015-2020 ($ millions)
Exhibit 10: Transcatheter mitral valve replacement market in EMEA 2015-2020 ($ millions)
Exhibit 11: Transcatheter mitral valve replacement market in APAC 2015-2020 ($ millions)
Exhibit 12: Impact of drivers
Exhibit 13: Impact of drivers and challenges
Exhibit 14: Major acquisitions 2015
Exhibit 15: Products of few vendors 2015
Exhibit 16: Abbott Laboratories: Key takeaways
Exhibit 17: Edwards Lifesciences: Business segmentation by revenue 2014
Exhibit 18: Edwards Lifesciences: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 19: Edwards Lifesciences: Key takeaways
Exhibit 20: Micro Interventional Devices: Key takeaways
Exhibit 21: Neovasc: Geographical segmentation by revenue 2014
Exhibit 22: Neovasc: Key takeaways
Exhibit 23: Other vendors
Exhibit 24: Emerging vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Edwards Lifesciences
  • MitrAssist
  • Neovasc
  • Valtech
  • MORE
New Report Released: - Global Transcatheter Mitral Valve Replacement Market 2016-2020

The author of the report recognizes the following companies as the key players in the global transcatheter mitral valve replacement market: Abbott Laboratories, Edwards Lifesciences, Micro Interventional Devices, and Neovasc.

Other Prominent Vendors in the market are MitrAssist, NaviGate Cardiac Structures, and Valtech.

Commenting on the report, an analyst from the research team said that the development of novel products will promote growth for this market. Advances in technology, material, and design of prosthetic valves and delivery devices have led surgeons to perform mitral valve replacement procedures with better post-surgical outcomes. The growing focus on compatibility and durability of implants in the human body led cardiologists to prefer transcatheter mitral valves to mechanical prosthetic valves. The shift from open-heart procedures to minimally invasive methods for the implantation of devices since 2005 has been a breakthrough in the demand and sales of heart valves.

According to the report, prevalence of mitral regurgitation is one of the drivers that led to the growth of this market. Mitral regurgitation is a common heart valve disorder that affects 2%-3% of the population worldwide. The disorder is becoming prevalent among all age groups rapidly. About 0.5% of individuals aged 18-45 and 9% of people aged 60-75 have this disorder. In 2009, research studies estimated that more than 176 million people worldwide have the disorder. These studies also estimated that more than four million individuals in the US had mitral regurgitation. Of this number, about one in 10 individuals was aged 75 and above.

Further, the report states that availability of alternative treatment is negatively affecting the sales of transcatheter mitral valve implants. Transcatheter mitral valve replacement is a minimally invasive surgical procedure. This procedure has been proven to be safe and efficient, improving the quality of life. However, mitral valve repair surgical procedures are medical consultants' first choice for treating mitral regurgitation. Mitral valve repair surgery involves the implantation of a stent-like device for reshaping the posterior region of the annulus to repair the damaged mitral valve. The surgical procedure offers better postoperative left ventricular function, lowers long-term morbidity, and increases life expectancy compared to transcatheter mitral valve replacement procedure. Cardiac Dimensions' Carillon and Edwards Lifesciences' Monarc are two major mitral valve repair devices available in the market. These devices are less expensive compared to transcatheter mitral valve replacement devices.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Abbott Laboratories
- Edwards Lifesciences
- Micro Interventional Devices
- Neovasc
- MitrAssist
- NaviGate Cardiac Structures
- Valtech
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll